$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000121390022048180 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2021 Q4
Revenue	$4.130M	$7.555M	$8.453M
YoY Change	-53.32%	-36.27%	15.0%
Cost Of Revenue	$4.295M	$6.783M	$10.28M
YoY Change	-50.87%	-31.09%	78.71%
Gross Profit	-$165.2K	$772.0K	-$1.823M
YoY Change	-257.2%	-61.62%	-213.25%
Gross Profit Margin	-4.0%	10.22%	-21.57%
Selling, General & Admin	$1.042M	$888.3K	$347.5K
YoY Change	-63.2%	-21.59%	-88.68%
% of Gross Profit		115.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$106.3K	$106.2K	$145.7K
YoY Change	10.17%	-0.99%	61.9%
% of Gross Profit		13.75%
Operating Expenses	$2.337M	$2.100M	$347.5K
YoY Change	-17.47%	8.49%	-88.68%
Operating Profit	-$2.502M	-$1.328M	-$2.171M
YoY Change	-8.23%	-1848.72%	48.68%
Interest Expense	$52.76K	$73.13K	$15.70K
YoY Change	17906.14%	22126.75%	-21.5%
% of Operating Profit
Other Income/Expense, Net	-$45.97K	$310.3K	$1.130K
YoY Change	91.13%	316.5%
Pretax Income	-$2.548M	-$1.018M	-$2.164M
YoY Change	-7.36%	-776.48%	50.26%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.454M	-$1.415M	-$3.427M
YoY Change	-35.95%	-8.17%	110.22%
Net Earnings / Revenue	-59.41%	-18.73%	-40.54%
Basic Earnings Per Share	-$0.18	-$0.11
Diluted Earnings Per Share	-$182.3K	-$107.0K	-$312.5K
COMMON SHARES
Basic Shares Outstanding	12.05M shares	13.23M shares	11.99M shares
Diluted Shares Outstanding	13.46M shares	13.23M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.118M	$2.428M	$13.02M
YoY Change	-35.63%	4.5%	0.11%
Cash & Equivalents	$2.118M	$2.428M	$13.02M
Short-Term Investments
Other Short-Term Assets	$2.585M	$4.183M	$3.200M
YoY Change	-87.07%	-80.08%	461.4%
Inventory	$895.0K	$928.1K	$1.274M
Prepaid Expenses
Receivables	$1.713M	$2.510M	$2.918M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.87M	$15.19M	$17.91M
YoY Change	32.67%	66.41%	-2.1%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.881M	$4.807M	$6.840M
YoY Change	-29.62%	-33.03%	154.94%
Goodwill	$1.309M	$1.309M	$1.309M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$1.973M	$2.013M	$2.095M
YoY Change		-7.61%	-5.56%
Long-Term Investments	$4.449M	$4.300M	$3.800M
YoY Change	28.39%	28.34%
Other Assets	$81.57K	$91.77K	$112.2K
YoY Change	-33.34%	-30.77%	-25.23%
Total Long-Term Assets	$17.08M	$16.95M	$17.01M
YoY Change	6.96%	3.79%	98.16%
TOTAL ASSETS
Total Short-Term Assets	$11.87M	$15.19M	$17.91M
Total Long-Term Assets	$17.08M	$16.95M	$17.01M
Total Assets	$28.96M	$32.14M	$34.92M
YoY Change	16.19%	26.25%	29.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.494M	$4.463M	$3.785M
YoY Change	-51.04%	-24.62%	25.64%
Accrued Expenses	$457.8K	$459.7K	$318.0K
YoY Change	45.15%	10.4%	2.57%
Deferred Revenue	$1.274M	$1.770M	$1.438M
YoY Change	8.35%	124.27%	-19.0%
Short-Term Debt	$0.00	$0.00	$23.73K
YoY Change	-100.0%
Long-Term Debt Due	$16.57K	$19.79K	$19.49K
YoY Change	-14.37%	3.07%	-2.55%
Total Short-Term Liabilities	$7.749M	$8.715M	$11.59M
YoY Change	-28.54%	15.06%	60.15%
LONG-TERM LIABILITIES
Long-Term Debt	$750.0K	$751.7K	$761.6K
YoY Change	4426.25%	3402.7%	2438.8%
Other Long-Term Liabilities	$2.195M	$2.308M	$860.5K
YoY Change	133.33%	126.14%	-27.08%
Total Long-Term Liabilities	$2.945M	$3.060M	$1.622M
YoY Change	207.62%	193.6%	34.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.749M	$8.715M	$11.59M
Total Long-Term Liabilities	$2.945M	$3.060M	$1.622M
Total Liabilities	$10.69M	$11.78M	$13.21M
YoY Change	-9.38%	36.65%	56.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.70M	-$35.24M	-$33.11M
YoY Change	26.99%	36.32%	48.63%
Common Stock	$120.5K	$120.5K	$119.9K
YoY Change	36.58%	36.58%	39.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$49.68K
YoY Change
Treasury Stock Shares	23.12K shares
Shareholders Equity	$17.63M	$19.54M	$20.35M
YoY Change
Total Liabilities & Shareholders Equity	$28.96M	$32.14M	$34.92M
YoY Change	16.19%	26.25%	29.92%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2021 Q4
OPERATING ACTIVITIES
Net Income	-$2.454M	-$1.415M	-$3.427M
YoY Change	-35.95%	-8.17%	110.22%
Depreciation, Depletion And Amortization	$106.3K	$106.2K	$145.7K
YoY Change	10.17%	-0.99%	61.9%
Cash From Operating Activities	-$190.6K	-$8.620M	$369.7K
YoY Change	-169.18%	-1088.42%	-76.3%
INVESTING ACTIVITIES
Capital Expenditures	-$244.2K	-$490.3K	-$648.9K
YoY Change	115.4%	-87.22%	-57.31%
Acquisitions
YoY Change
Other Investing Activities	-$227.5K	-$726.4K	-$538.8K
YoY Change	-411.4%	-78.75%	498.67%
Cash From Investing Activities	-$471.7K	-$1.217M	-$1.188M
YoY Change	1070.28%	-83.23%	-26.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	352.3K	-882.0K	10.55M
YoY Change	-51.86%	-51.95%
NET CHANGE
Cash From Operating Activities	-190.6K	-8.620M	369.7K
Cash From Investing Activities	-471.7K	-1.217M	-1.188M
Cash From Financing Activities	352.3K	-882.0K	10.55M
Net Change In Cash	-310.0K	-10.72M	9.734M
YoY Change	-132.06%	30.44%	-19567.36%
FREE CASH FLOW
Cash From Operating Activities	-$190.6K	-$8.620M	$369.7K
Capital Expenditures	-$244.2K	-$490.3K	-$648.9K
Free Cash Flow	$53.59K	-$8.129M	$1.019M
YoY Change	-86.22%	-272.69%	-66.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	usd
	sgbx	License Agreement Initial Term LicenseAgreementInitialTerm	P5Y
	sgbx	License Agreement Automatically Renew Term LicenseAgreementAutomaticallyRenewTerm	P5Y
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12050026	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38037
	dei	Entity Registrant Name EntityRegistrantName	SG BLOCKS, INC.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5011 Gate Parkway,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building 100, Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	Jacksonville
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32256
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	240-4235
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	SGBX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12050206	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2428211	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13024381	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4000000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2510192	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	usd
CY2022Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent		usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	41916	usd
CY2022Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4392541	usd
CY2021Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent		usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	928120	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1273825	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	933036	usd
CY2022Q2	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	808761	usd
CY2021Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	923172	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1309330	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1309330	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	656279	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	15192100	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	17914047	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4806650	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6839943	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2779191	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1210053	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	838733	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	720137	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2013028	usd
CY2022Q2	us-gaap	Deferred Costs DeferredCosts	91767	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	112159	usd
CY2022Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	200000	usd
CY2022Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599943	usd
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	usd
CY2022Q2	us-gaap	Assets Assets	32139503	usd
CY2021Q4	us-gaap	Assets Assets	34924018	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4462673	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7568851	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1769604	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	479488	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	337469	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	264451	usd
CY2022Q2	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2021Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2022Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1997843	usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	1971960	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8715403	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11586105	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	750000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2310017	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	872124	usd
CY2022Q2	us-gaap	Liabilities Liabilities	11775420	usd
CY2021Q4	us-gaap	Liabilities Liabilities	13208229	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54660934	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	53341405	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-35241757	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33109220	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	19539679	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11986873	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	120502	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	119869	usd
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11986873	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20352054	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	824404	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	1363735	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20364083	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32139503	usd
CY2022Q2	us-gaap	Revenues Revenues	7554971	usd
CY2021Q2	us-gaap	Revenues Revenues	11853987	usd
	us-gaap	Revenues Revenues	16159569	usd
	us-gaap	Revenues Revenues	21041614	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	6783011	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	9842606	usd
	us-gaap	Cost Of Revenue CostOfRevenue	12901174	usd
	us-gaap	Cost Of Revenue CostOfRevenue	18623607	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	771960	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	2011381	usd
	us-gaap	Gross Profit GrossProfit	3258395	usd
	us-gaap	Gross Profit GrossProfit	2418007	usd
CY2022Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1211509	usd
CY2021Q2	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	801664	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	2355696	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1629186	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	796812	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1060499	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1576833	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1720300	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	91495	usd
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	72438	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	234830	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	143065	usd
CY2022Q2	us-gaap	Pre Opening Costs PreOpeningCosts		usd
CY2021Q2	us-gaap	Pre Opening Costs PreOpeningCosts	847	usd
	us-gaap	Pre Opening Costs PreOpeningCosts		usd
	us-gaap	Pre Opening Costs PreOpeningCosts	10980	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2099816	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1935448	usd
	us-gaap	Operating Expenses OperatingExpenses	4167359	usd
	us-gaap	Operating Expenses OperatingExpenses	3503531	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1327856	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	75933	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-908964	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1085524	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	73126	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	329	usd
	us-gaap	Interest Expense InterestExpense	121975	usd
	us-gaap	Interest Expense InterestExpense	692	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	10979	usd
CY2021Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	13797	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	23762	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	31267	usd
CY2022Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	372407	usd
CY2021Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	61024	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	491309	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	61024	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	310260	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	74492	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	393096	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	91599	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1017596	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	150425	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-515868	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-993925	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1017596	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	150425	usd
	us-gaap	Profit Loss ProfitLoss	-515868	usd
	us-gaap	Profit Loss ProfitLoss	-993925	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	397764	usd
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1691684	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1616669	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2581211	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1415360	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1541259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2132537	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3575136	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13226451	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8822278	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13110821	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8783806	shares
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21632603	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	631076	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2022Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	882000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1017596	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20364083	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1320162	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2156000	usd
	us-gaap	Profit Loss ProfitLoss	-515868	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20364083	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18283097	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	246236	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3749	usd
CY2021Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1842784	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	150425	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16840723	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18437823	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	707187	usd
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1842784	usd
	us-gaap	Profit Loss ProfitLoss	-993925	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16840723	usd
	us-gaap	Profit Loss ProfitLoss	-515868	usd
	us-gaap	Profit Loss ProfitLoss	-993925	usd
	us-gaap	Depreciation Depreciation	210977	usd
	us-gaap	Depreciation Depreciation	198398	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82204	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	82230	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	20392	usd
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	20392	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	21569	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7024	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	161202	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	18596	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	18596	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1280162	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	532422	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-241	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-400430	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	245307	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	4000000	usd
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-41916	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	819095	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-345705	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	631771	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	276757	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16800	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-232401	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-204840	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3040292	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1958175	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	332025	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-985672	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-264451	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-583791	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-221627	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-204246	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5362545	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1307944	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1751999	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4693008	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	42500	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	760	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	100000	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	707187	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	500000	usd
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3077625	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8243216	usd
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition		usd
	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	157469	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	726386	usd
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	3350239	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2156000	usd
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1842784	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2156000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1135597	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10596170	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10686757	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13010356	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1801584	usd
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2020Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-20
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12050026	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12050026	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2428211	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	4183116	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4183116	usd
CY2021Q4	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	10488000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div> <p style="color: #000000; font: 10pt 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; margin: 0pt 0px 0pt 0.5in;"><span style="color: black;"><span style="border-left: none; border-right: none; line-height: inherit;"><span style="border-right: none; border-left: none; line-height: inherit;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, stock warrants liabilities and allowance for credit losses. Actual results could differ from those estimates.</span></span></span></p> </div> </div> </div> </div> </div> </div>
	sgbx	No Of Operating Cycles NoOfOperatingCycles	one year
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div style="border-right: none; border-left: none;"> <div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <p style="margin: 0pt 0pt 0pt 36pt; line-height: normal; font-size: 11pt; font-family: Calibri, 'sans-serif'; text-indent: 0pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"><b><i><span>Reclassification – </span></i></b></span><span style="font-size: 9.0pt; font-family: 'Times New Roman','serif';"><span style="font-family: 'times new roman', times; font-size: 10pt;">Certain prior year balances were reclassed to conform to current period presentation.<span style="mso-spacerun: yes;"> </span>There was no impact to income (loss) or cash flows as a result of these reclassifications</span>.<span style="mso-spacerun: yes;"> </span></span><span style="font-family: 'Times New Roman', 'serif'; font-size: 9pt; text-indent: 0pt;"> </span></p> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div>
	sgbx	Termofagreement Termofagreement	P2Y
CY2019Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.50	pure
CY2019Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2500	shares
CY2021Q1	sgbx	Common Stock Vest And Be Issued Shares CommonStockVestAndBeIssuedShares	1250	shares
CY2021Q3	sgbx	Common Stock Remaining Vest And Be Issued Shares CommonStockRemainingVestAndBeIssuedShares	1250	shares
	us-gaap	Restricted Cash And Cash Equivalent Item Description RestrictedCashAndCashEquivalentItemDescription	the event that the Agreement was earlier terminated, CMC was entitled to receive the entire amount of such restricted stock that had vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provided for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC.
	sgbx	Total Expected Gross Revenue TotalExpectedGrossRevenue	16900000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	10200000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	15600000	usd
	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	10203215	usd
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	5956354	usd
	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	15750903	usd
	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	5290711	usd
CY2022Q2	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	3317387	usd
CY2022Q2	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	4237584	usd
CY2021Q2	sgbx	Revenue Recognized At Point In Time RevenueRecognizedAtPointInTime	9785490	usd
CY2021Q2	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	2068497	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7554971	usd
CY2022Q2	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11853987	usd
CY2021Q2	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16159569	usd
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21041614	usd
	sgbx	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	1	pure
CY2022Q2	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	306143	usd
CY2022Q2	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	usd
CY2022Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	usd
CY2022Q2	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	112159	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20393	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20392	usd
	sgbx	License Consideration Description LicenseConsiderationDescription	In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) five percent (5%) on the first $20,000,000 of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) four and one-half percent (4.5%) on the next $30,000,000 of Gross Revenues, and (z) five percent (5%) on all Gross Revenues thereafter (collectively, the “Royalty”)
	sgbx	Minimum Royalty Payments One Year MinimumRoyaltyPaymentsOneYear	500000	usd
	sgbx	Minimum Royalty Payments Two Year MinimumRoyaltyPaymentsTwoYear	750000	usd
	sgbx	Minimum Royalty Payments Three Year MinimumRoyaltyPaymentsThreeYear	1500000	usd
	sgbx	Minimum Royalty Payments Four Year MinimumRoyaltyPaymentsFourYear	2000000	usd
	sgbx	Minimum Royalty Payments Five Year MinimumRoyaltyPaymentsFiveYear	2500000	usd
CY2021Q2	sgbx	Redemption Distributions RedemptionDistributions	1.25	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	502958	usd
CY2021	us-gaap	Other Income OtherIncome	60000	usd
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	600000	usd
CY2021Q2	us-gaap	Related Party Transaction Other Revenues From Transactions With Related Party RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty	350329	usd
CY2021Q2	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13024381	usd
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2022Q2	us-gaap	Escrow Deposit EscrowDeposit	2000000	usd
CY2022Q2	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	97164	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	897937	usd
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	732085	usd
CY2022Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	40382	usd
CY2021Q2	us-gaap	Adjustment For Amortization AdjustmentForAmortization	41823	usd
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P5Y
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	80764	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	161176	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	160469	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	157052	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	139717	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1313850	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2013028	usd
CY2021Q2	sgbx	Project Development Costs ProjectDevelopmentCosts	816410	usd
CY2021Q2	sgbx	Project Development Costs Book Value ProjectDevelopmentCostsBookValue	4392541	usd
CY2022Q2	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2021Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts	2238578	usd
CY2022Q2	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-3969959	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account. </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At June 30, 2022 and December 31, 2021, 79% and 78%, respectively, of the Company’s gross accounts receivable were due from <span style="border-left: none; border-right: none;">two</span> and four customers. </span></p> <p style="margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'times new roman', times; font-size: 10pt;">Revenue relating to two and one customers represented approximately 97% and 77% of the Company's total revenue for the <span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">three months ended June 30, 2022</span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"> and </span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">2021</span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">, respectively. Revenue relating to </span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">two</span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"> and </span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">one</span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"> customers represented approximately 90</span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">% and </span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">71</span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">% of the Company's total revenue for the </span></span> six months ended June 30, 2022 and 2021, respectively. </span></p> <p style="margin: 0pt; text-indent: 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: #000000; font-family: 'times new roman', times; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Cost of revenue relating to one and two <span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">vendors represented approximately </span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">12</span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">% and </span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">52</span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">% of the Company’s total cost of revenue for the </span></span><span><span style="font-size: 10.0pt; font-family: 'Times New Roman','serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">three months ended June 30, 2022</span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;"> and </span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">2021</span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">, respectively Cost of revenue relating to </span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">one</span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;"> and </span></span><span><span style="font-size: 10pt; font-family: 'Times New Roman', 'serif'; color: #000000;">three</span></span> vendors represented approximately 10% and 48% of the Company’s total cost of revenue for the six months ended June 30, 2022 and 2021, respectively. </span><span style="color: #000000; font-family: 'times new roman', times; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span></span></p>
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3473308	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3880762	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2510192	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7024	usd
	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	167202	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2021Q2	us-gaap	Depreciation Depreciation	107208	usd
CY2022Q2	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	11848306	usd
CY2021Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4272425	usd
CY2021Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	-3156377	usd
CY2022Q2	sgbx	Contract Assets Gross ContractAssetsGross	7878347	usd
CY2021Q4	sgbx	Contract Assets Gross ContractAssetsGross	3354626	usd
CY2021Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	4750289	usd
CY2022Q2	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-1769604	usd
CY2021Q4	sgbx	Netcontractliabilitiesonuncompletedcontracts Netcontractliabilitiesonuncompletedcontracts	-1395663	usd
CY2022Q2	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent		usd
CY2021Q4	sgbx	Contract With Customer Assets Net Current ContractWithCustomerAssetsNetCurrent	41916	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1769604	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	usd
CY2022Q2	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-1769604	usd
CY2021Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-1395663	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5426387	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7249222	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	619737	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4806650	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6839943	usd
CY2022Q2	us-gaap	Depreciation Depreciation	106152	usd
CY2021	sgbx	Short Term Debt Interest Charges ShortTermDebtInterestCharges	112348	usd
	us-gaap	Depreciation Depreciation	210977	usd
	us-gaap	Depreciation Depreciation	198398	usd
CY2021Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	usd
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	usd
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2022Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	0	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4314	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	23727	usd
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	usd
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	usd
CY2022Q2	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	2756669	usd
CY2022Q2	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	459701	usd
CY2022Q2	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	2308341	usd
CY2022Q2	sgbx	Totaloperatingleaseliabilities Totaloperatingleaseliabilities	-2768042	usd
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	22522	usd
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	19787	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1676	usd
CY2022Q2	sgbx	Totalfinanceleaseliabilities Totalfinanceleaseliabilities	-21463	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M9D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	270550	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	10080	usd
CY2022Q2	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	207379	usd
CY2022Q2	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	280630	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	525718	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	11760	usd
CY2022Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	537478	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	523722	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2022Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	523722	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	446349	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2022Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	446349	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	207379	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1119903	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2022Q2	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	1119903	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3093621	usd
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	21840	usd
CY2022Q2	us-gaap	Other Commitment OtherCommitment	3115461	usd
CY2022Q2	sgbx	Total Operating Imputed Interest TotalOperatingImputedInterest	325579	usd
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	377	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	325956	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2768042	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	21463	usd
CY2022Q2	sgbx	Presentvalueofleaseliabilities Presentvalueofleaseliabilities	2789505	usd
	sgbx	Sublease Term SubleaseTerm	P1Y
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
CY2020Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	25117461	usd
	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	7018469	usd
CY2021	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	3191335	usd
	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	96908	usd
CY2021	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	18297197	usd
	sgbx	Construction Backlog Gross ConstructionBacklogGross	10139470	usd
CY2021	sgbx	Construction Backlog Gross ConstructionBacklogGross	10011599	usd
	sgbx	Contract Revenue ContractRevenue	5956354	usd
CY2021	sgbx	Contract Revenue ContractRevenue	6793690	usd
CY2022Q2	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	4183116	usd
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
CY2021	sgbx	Contract Backlog Description ContractBacklogDescription	two contracts entered into during the third quarter of 2020 in the amount of approximately $4 million and approximately $2.95 million
	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	number
	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	1.3	usd
CY2021Q3	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	number
CY2021Q3	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	870000	usd
CY2021Q3	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	number
CY2021Q3	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	1300000	usd
CY2021Q4	sgbx	Number Of Large Contracts NumberOfLargeContracts	1	number
CY2021Q4	sgbx	Construction Backlog Contract Revenue ConstructionBacklogContractRevenue	780000	usd
CY2021Q4	sgbx	Number Of Large Contracts Cancelled Partially NumberOfLargeContractsCancelledPartially	1	number
CY2021Q4	sgbx	Cancellation Of Construction Backlog Contract Amountbacklogcontract CancellationOfConstructionBacklogContractAmountbacklogcontract	16900000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4183116	usd
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	usd
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	45000	shares
CY2019Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	17
CY2017Q2	sgbx	Warrants To Purchase WarrantsToPurchase	4313	shares
CY2017Q2	us-gaap	Share Price SharePrice	125
CY2017Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-21
CY2017Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	63796	usd
CY2020Q2	sgbx	Warrants To Purchase WarrantsToPurchase	300000	shares
CY2020Q2	us-gaap	Share Price SharePrice	3.14
CY2020Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-05-05
CY2021Q4	sgbx	Warrants To Purchase WarrantsToPurchase	1898630	shares
CY2021Q4	us-gaap	Share Price SharePrice	4.8
CY2021Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2016Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	25000	shares
CY2016Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3625000	shares
CY2022Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1343377	shares
	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	1280162	usd
	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	532422	usd
CY2022Q2	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	631076	usd
CY2021Q2	sgbx	Stock Based Compensation Expense Total StockBasedCompensationExpenseTotal	246236	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36436	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.8
CY2022Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	78.71
	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P4Y10M2D
CY2022Q2	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2021Q4	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4M2D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	36436	shares
CY2022Q2	sgbx	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	24.8
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	78.71
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M2D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2666	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized		usd
CY2022Q2	us-gaap	Share Price SharePrice	1.66
CY2019Q1	sgbx	Number Of Consultants NumberOfConsultants	1	consultants
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of six employees and one consultant of 6,139, 772, 5,729 and an aggregate of 3,063, respectively, vest in installments over either a one-year, two-year, three-year and four-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $847,957.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date as adjusted for stock splits.
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms	a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date as adjusted for stock splits.
CY2019Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	9189	shares
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.4
	sgbx	Options Vested Description OptionsVestedDescription	the Company’s common stock for the ten trading days immediately preceding and including the grant date. Restricted stock units granted to directors on June 5, 2019 vest on the earlier of (A) the first anniversary of the date of the grant or (B) the date of the annual meeting of the Company’s stockholders that occurs in the year immediately following the date of the grant; and are payable six months after the termination of the director from the Board or death or disability.
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	425000	shares
CY2020Q3	sgbx	Number Of Consultants NumberOfConsultants	1	consultants
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.81
CY2020Q3	sgbx	Options Vested Description OptionsVestedDescription	the Company's common stock on September 23, 2020. Restricted stock units granted to Mr. Armstrong, Mr. Sheeran, and an aggregate of seven employees and one consultant of 50,000, 75,000 and an aggregate of 300,000, respectively, and 1/3 will vest on September 23, 2020, 1/3 on the one year anniversary of the grant date and 1/3 on the two year anniversary of the grant date. The fair value of these units upon issuance amounted to $769,250.
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1214500	shares
CY2021Q4	us-gaap	Share Price SharePrice	3.38
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	475000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1274137	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	425998	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	90689	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	757450	shares
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2100000	usd
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	usd
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	usd
CY2019Q2	sgbx	Unpaid Wages UnpaidWages	30428.71	usd
CY2021Q3	sgbx	Recovery Of Damages Sought RecoveryOfDamagesSought	67125.83	usd
CY2020Q1	sgbx	Unpaid Wages UnpaidWages	372638	usd
CY2020Q1	sgbx	Severance Amount SeveranceAmount	300000	usd
CY2020Q2	sgbx	Severance Amount SeveranceAmount	300000	usd
CY2021Q2	us-gaap	Unrecorded Unconditional Purchase Obligation Period Quantity Purchased UnrecordedUnconditionalPurchaseObligationPeriodQuantityPurchased	2000000	shares
CY2021Q2	us-gaap	Other Commitments Description OtherCommitmentsDescription	provide for an annual base salary of $400,000 provide for a performance bonus structure for a bonus of up to 50% of base salary upon the Company’s achievement of $2,000,000 EBITDA and additional performance bonus payments for the achievement of EBITDA in excess of $2,000,000 based on a percentage of the incremental increase in EBITDA (ranging from 10% of the incremental increase in EBITDA if the Company achieves over $2,000,000 and up to $7,000,000 in EBITDA, 8% of the incremental increase in EBITDA if the Company achieves over $7,000,000 and up to $12,000,000 in EBITDA and 3% of the incremental increase in EBITDA over $12,000,000), provide for a profits-based additional bonus of up to $250,000 in certain limited circumstances, and provide for one (1) year severance, plus a pro-rated amount of any unpaid bonus earned by him during the year as verified by the Company’s principal financial officer, if Mr. Galvin is terminated without cause. At the Company’s option, up to fifty (50%) percent of the EBITDA performance bonuses may be paid in restricted stock units if then available for grant under the Company’s Stock Incentive Plan.All other terms of the employment agreement remain in full force and effect.
CY2022Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	500000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2095232	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2428211	usd

Files In Submission

Name	View Source	Status
0001213900-22-048180-index-headers.html	Edgar Link	pending
0001213900-22-048180-index.html	Edgar Link	pending
0001213900-22-048180.txt	Edgar Link	pending
0001213900-22-048180-xbrl.zip	Edgar Link	pending
ex311_1.htm	Edgar Link	pending
ex321_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20220630.htm	Edgar Link	pending
sgbx-20220630.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sgbx-20220630_def.xml	Edgar Link	unprocessable
sgbx-20220630_pre.xml	Edgar Link	unprocessable
sgbx-20220630_lab.xml	Edgar Link	unprocessable
sgbx-20220630_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sgbx-20220630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2022 Q3 Form 10-Q Financial Statement

#000121390022048180 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2022 Q3 Form 10-Q Financial Statement

#000121390022048180 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx